Web developer

Education: IT formal degree, programming degree/certification compulsory (Brainbench certificates are appropriate) for the specified technologies. English knowledge compulsory.
Competencies: Required technologies are php/Mysql (front end and back end), Flash, html, image processing. Portfolio is mandatory. Attention to detail and pro-active approach are essential for successful candidates

Maintenance of the present project website, www.teddyoung.org, implementation of new features or further enhancements as required by the partners' needs.
Needs to secure perfect functioning of the website, optimal access to information, smooth end user experience.
The activity includes implementation of SEO strategies.

The Romanian Angel Appeal Foundation (RAA) is the Romanian partner of TEDDY. RAA is coordinating a team of Romanian top academics/researchers in their TEDDY involvement and is the leader of Communication, Information and Learning activities delivering mainly through the project website www.teddyoung.org, newsletter, medical e-learning modules.
In order to ensure great visibility and access to TEDDY project results through the website, electronic newsletter and e-learning modules, a web developer is being recruited.
The Task-force in Europe for Drug Development for the Young (TEDDY) is a Network of Excellence funded under the Sixth EU Framework Programme for Research and Technological Development (FP6).
The project started in June 2005 and is expected to run until 2010. It involves 19 partners from 11 countries.
The overall aim of TEDDY is promoting the availability of safe and effective medicines for children in Europe by integrating existing expertises and good practices, as well as stimulating further developments.

TEDDY specific OBJECTIVES include:
1- To establish a rationale for the safe and efficacious use of medicines in male/female children based on an understanding of developmental biology, pharmacogenetics and pharmacogenomics.
2- To identify unmet needs for the development and use of medicinal products and orphan drugs in male/female children.
3- To develop, validate and harmonise pre-clinical and clinical methods for assessing the safety and efficacy of current and new drugs in male/female children.
4- To explore, validate and consolidate the existing data sources containing information on medicines used in male/female children before setting up a harmonised, integrated and reliable European database (or system of databases) to provide an information centre service.
5- To increase awareness of, and contribute to the debate on the ethical issues arising from paediatric drug research and use (including off-label and unlicensed use), and the extended use of biotechnology for diagnostic and therapeutic purposes.
6- To bring together industries and other relevant stakeholders to encourage the development of new drugs, to optimise paediatric formulations and provide labelling recommendations for current drugs.
7- To build critical mass capacity by means of training and education activities, the dissemination of information and the development of guidelines.